4//SEC Filing
Xenon Pharmaceuticals Inc. 4
Accession 0001171843-16-009007
$XENECIK 0001582313operating
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 6:58 PM ET
Size
5.3 KB
Accession
0001171843-16-009007
Insider Transaction Report
Form 4
WINQUIST RAYMOND
Head, Translational Research
Transactions
- Award
Stock Option (Right to Buy)
2016-04-04+35,000→ 35,000 totalExercise: $7.10Exp: 2026-04-03→ Common Shares (35,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on April 4, 2017, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001582313
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 6:58 PM ET
- Size
- 5.3 KB